NCT02688322View on ClinicalTrials.gov

Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Acinetobacter Infections
Interventions
DRUG

Sulbactam

2 g in 100 ml of normal saline solution and administered via an infusion pump at a constant flow rate 1 h every 12 h. Blood samples (approximately 5 ml) will be obtained by direct venepuncture at the following time: 0, 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8 and 12 h after 7th dose of sulbactam

Trial Locations (1)

90110

Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai

All Listed Sponsors
collaborator

Prince of Songkla University

OTHER

lead

Sutep Jaruratanasirikul

OTHER

NCT02688322 - Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections | Biotech Hunter | Biotech Hunter